Treg cells are involved in tumor progression by explicitly improving the expression of CTLA4; glucocorticoid-induced TNF receptor (GITR); IL-2, IL-10 and IL-35; lymphocyte-activation gene-3 (LAG3); and TGF-β. Here, IL2 is linked to neoplasm.